INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 88 filers reported holding INSMED INC in Q3 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,630,090 | -38.8% | 64,558 | -24.4% | 0.32% | -34.0% |
Q4 2017 | $2,664,000 | -1.3% | 85,424 | -1.3% | 0.48% | +32.9% |
Q3 2017 | $2,700,000 | +147.9% | 86,522 | +3.7% | 0.36% | +62.4% |
Q3 2014 | $1,089,000 | -51.8% | 83,453 | -26.2% | 0.22% | -48.5% |
Q2 2014 | $2,258,000 | -61.0% | 113,017 | -62.8% | 0.43% | -58.9% |
Q1 2014 | $5,789,000 | +19.4% | 304,022 | +6.6% | 1.04% | +20.2% |
Q4 2013 | $4,849,000 | +46.9% | 285,097 | +3.3% | 0.87% | +21.2% |
Q2 2013 | $3,300,000 | – | 275,956 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |